Global Health Share Initiative: Difference between revisions
No1lakersfan (talk | contribs) Added {{Update}} tags (within {{multiple issues}}) tag to article (TW) |
m Normalize {{Multiple issues}}: Remove {{Multiple issues}} for only 1 maintenance template(s): Update |
||
| Line 1: | Line 1: | ||
{{Multiple issues| |
|||
{{Orphan|date=February 2013}} |
{{Orphan|date=February 2013}} |
||
{{Update|date=July 2019}} |
{{Update|date=July 2019}} |
||
}} |
|||
Global HealthShare® initiative (GHS) is a program launched in June 2010 by the [[University of California, Davis]] Center of Excellence for [[Nutritional genomics|Nutritional Genomics]]. The program plans to share resources to improve the health in [[developing countries]]. Alliances with other research institutions, humanitarian organizations and private companies around the world have been made to meet this goal. |
Global HealthShare® initiative (GHS) is a program launched in June 2010 by the [[University of California, Davis]] Center of Excellence for [[Nutritional genomics|Nutritional Genomics]]. The program plans to share resources to improve the health in [[developing countries]]. Alliances with other research institutions, humanitarian organizations and private companies around the world have been made to meet this goal. |
||
Revision as of 07:37, 31 May 2020
 | This article needs to be updated. (July 2019) |
Global HealthShare® initiative (GHS) is a program launched in June 2010 by the University of California, Davis Center of Excellence for Nutritional Genomics. The program plans to share resources to improve the health in developing countries. Alliances with other research institutions, humanitarian organizations and private companies around the world have been made to meet this goal.
The organization will use a multidisciplinary approach against chronic and infectious disease, breaking down their efforts into two main research "cores": the Nutrition Core and Mucosal Immunity Core. The former focuses on fighting malnutrition and the latter on developing new ways to deliver vaccines more effectively to developing countries. The program differentiates itself from others like it by focusing on the delivery of the beneficial product to the end-user rather than the academic research process.